- IN₹229.07bn
- IN₹234.65bn
- IN₹53.66bn
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake
Brief: Granules Says Promoter Krishna Prasad Chigurupati Sells 17.2 Million Shares Of Co Via Block Deal
Granules India's first-quarter profit surges as margins improve
Granules India rises after quarterly profit increase
Brief: Granules India Q1 Consol Profit 1.8 Billion Rupees
Brief: Granules Secures First-To-File ANDA Status For Generic Lumryz
Brief: Granules Receives US FDA Eir With Voluntary Action Indicated For Chantilly Facility
India's Granules jumps on Q4 profit growth
Granules India hits record high on Q4 profit, revenue jump
Granules India's fourth-quarter profit jumps on strong demand
Brief: Granules India Q4 Consol Profit 2.02 Billion Rupees
Indian drugmaker Granules to tighten oversight after US FDA warning, exec says
Brief: Granules Receives VAI Classification After US FDA Inspection
Brief: Granules Says Packaging Facility In US Gets FDA EIR With No Action Indicated Status
Granules India's rises on quarterly profit jump
Granules India quarterly profit jumps on strong demand in North America, Europe